Inactive Instrument
Achillion Pharmaceuticals, Inc. Share Price
Stocks
US00448Q2012
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Treasurer | 54 | 27/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 27/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/01/20 | Issuer sale | Chief Operating Officer | 600,000 | 0.4283% | ||
| 28/01/20 | Issuer sale | Chief Financial Officer | 700,000 | 0.4997% | ||
| 28/01/20 | Issuer sale | Chairman | 308,431 | 0.2202% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +9.21% | - | - | 947M | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.56B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 54.19B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 44.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 40.51B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.27B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.89B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.26B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.01B | ||
| Average | -1.24% | -1.22% | +33.67% | +175.26% | 44B | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
Employees
-
















